In vitro findings have shown the pro-oncogenic impact of leptin, including cell proliferation, transformation, apoptosis regulation, self-renewal, and reduced sensitivity to breast cancer treatments (reviewed in [224,225,226]). This evidence concerns the gene LEP and breast cancer.